Comment

Novartis partners with Advara HeartCare and TerryWhite Chemmart to launch Heart Health Collective, December 6, 2024

Advara HeartCare, the world’s largest single group of cardiologists, has joined forces with Novartis and TerryWhite Chemmart to form The Heart Health Collective.

Pfizer Australia launches Innovate Reconciliation Action Plan to advance equitable access to health and wellbeing December 6, 2024

"I am deeply thankful to our First Nations Advisors for all their time and wisdom, trust and vouching," said Leigh Simmonds, Pfizer Australia RAP Champion and senior manager for patient advocacy.

Former CSL CEO Paul Perreault appointed strategic adviser to Microbio December 5, 2024

Mr Perreault was the CEO and managing director of CSL from 2013 to 2023, leading the organisation to become the ﬁfth largest biotechnology company in the world.

More evidence backs the use of weight-loss therapies December 5, 2024

Eli Lilly Australia and New Zealand associate vice president of the company's cardiometabolic health business unit, Kelly Frankel, said, "SURMOUNT-5 answers a burning question for doctors and their chronic weight management patients.”

ChatGPT would have produced more human responses than these committees December 5, 2024

In their written responses to the recommendations, the Pharmaceutical Benefits Advisory Committee and Medical Services Advisory Committee have blithely ignored these community concerns in that Marie-Antoinette 'let them eat cake' way.

Anatara provides irritable bowel syndrome clinical trial update December 4, 2024

Anatara Lifesciences (ASX:ANR) has provided an update on the recruitment progress for Stage 2 of its pivotal GaRP-IBS - irritable bowel syndrome - trial.

Digital health company Adherium secures R&D loan facility December 4, 2024

Australian digital inhaler technology company Adherium (ASX:ADR) has entered into a $674,000 R&D loan facility with Endpoints Capital.

Australians rank access to affordable healthcare as second most important priority December 4, 2024

According to the results of a new survey commissioned by Medicines Australia, around one in six Australians have been unable to pay for needed medical services.

London Agency bolsters public affairs team with crossbench experience December 4, 2024

London Agency has expanded its government affairs offering by recruiting former crossbench staffer Kaya Hill.

Acrux says US FDA approves its nitroglycerin ointment for moderate to severe pain December 4, 2024

Acrux CEO and managing director Michael Kotsanis said, “We are very pleased to receive FDA approval for another ANDA product which has been developed in house by the Acrux R&D team."

Alterity Therapeutics completes last patient visit in ATH434-201 trial in multiple system atrophy December 4, 2024

Alterity Therapeutics (ASX:ATH) has announced that the last patient in its ATH434-201 Phase 2 trial in early-stage multiple system atrophy has completed the study.

Greens announce plan to make contraception more widely accessible December 4, 2024

“We are in a cost-of-living crisis and in the face of financial stress and gender inequality, the Greens will take to the election a commitment to provide women with free access to contraceptives," said Senator Larissa Waters.

Latest Video

Most Read

ChatGPT would have produced more human responses than these committees

More evidence backs the use of weight-loss therapies

Novartis partners with Advara HeartCare and TerryWhite Chemmart to launch Heart Health Collective,

Pfizer Australia launches Innovate Reconciliation Action Plan to advance equitable access to health and wellbeing

Former CSL CEO Paul Perreault appointed strategic adviser to Microbio

New Stories

Novartis partners with Advara HeartCare and TerryWhite Chemmart to launch Heart Health Collective,

Pfizer Australia launches Innovate Reconciliation Action Plan to advance equitable access to health and wellbeing

Former CSL CEO Paul Perreault appointed strategic adviser to Microbio

More evidence backs the use of weight-loss therapies

ChatGPT would have produced more human responses than these committees

Anatara provides irritable bowel syndrome clinical trial update

Digital health company Adherium secures R&D loan facility

Sign In

Latest Video

Most Read

ChatGPT would have produced more human responses than these committees

More evidence backs the use of weight-loss therapies

Novartis partners with Advara HeartCare and TerryWhite Chemmart to launch Heart Health Collective,

Pfizer Australia launches Innovate Reconciliation Action Plan to advance equitable access to health and wellbeing

Former CSL CEO Paul Perreault appointed strategic adviser to Microbio

Follow Us

New Stories

Novartis partners with Advara HeartCare and TerryWhite Chemmart to launch Heart Health Collective,

Pfizer Australia launches Innovate Reconciliation Action Plan to advance equitable access to health and wellbeing

Former CSL CEO Paul Perreault appointed strategic adviser to Microbio

More evidence backs the use of weight-loss therapies

ChatGPT would have produced more human responses than these committees

Anatara provides irritable bowel syndrome clinical trial update

Digital health company Adherium secures R&D loan facility